CSI Market
Sign In | Register

Palisade Bio Inc (PALI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PALI Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Palisade Bio Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-20.17
Depreciation & amortization0.00
Amortization of Other Assets0.00
Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation9.07
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Other Nonoperating Expense-
Derivative Gain Loss On Derivative Net-
Increase Decrease In R O U And Other Assets-
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities Noncash Transaction Costs Shared With Acquiree-
Noncash Lease Expense-
Accounts Payable Written Off-
Vesting Expense Restricted Stock Units-
Noncash Operating Lease Expense-
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities-0.52
Increase (Decrease) in Accounts Payable and Accrued Liabilities2.04
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.92
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.82
Discontinued operations0.00
Net Cash flow from Operating Activities-11.49
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.07
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.35
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Public And Private Placement-
Payment Of Employee Taxes On Stock Option Exercise-
Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs-
Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs-
Payments Of Fees Related To Prior Financing-
Proceeds From Issuance Of Common Stock Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations133.44
Payment Of Warrant Inducement Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.28
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-11.49
Total Cash Flow-8.21
4 historic quarters locked

Sign in to unlock the full Palisade Bio Inc cash flow history.

Sign In Create Free Account

About Palisade Bio Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001357459-26-000016

Figures are derived from filed reports and may be restated. Historical data is subject to revision.